undamentalytics Newsletter
Sign in

Burning Rock Biotech Ltd key statistics and ratios

In fiscal 2025, Burning Rock Biotech Ltd had return on equity of -9.9% and a net margin of -10.3%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Net margin−85.0%−44.3%−94.7%−156.9%−172.4%−121.6%−67.2%−10.3%
Return on equity——−48.6%−37.4%−63.2%−66.9%−51.3%−9.9%
Return on assets—−20.1%−22.3%−32.3%−49.2%−49.1%−36.0%−6.5%
R&D as % of revenue50.4%41.1%61.4%72.4%74.9%64.6%45.0%30.9%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

6 of 7 checks passed · December 31, 2025
What it owns · $117m
Short-term assets $106mLonger-term assets $12m
What it owes, and who funded it · $117m
Short-term liabilities $35mLonger-term liabilities $5mShareholders' equity $77m
  • Short-term assets cover short-term liabilities $106m of assets due within a year against $35m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $106m short-term assets against $5m of longer-dated liabilities.
  • More cash than debt $68m of cash against $243,097 of debt.
  • Debt below 40% of shareholders' equity Debt is 0% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 0% to 0% over five years.
  • A year's operating cash flow covers at least 20% of debt −$4m of operating cash flow against $243,097 of debt.
  • Operating profit covers interest at least five times over No material interest expense reported.

From Burning Rock Biotech Ltd's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: BNR vs CDXSBNR vs XGNBNR vs PSNLBNR vs HBIO

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Burning Rock Biotech Ltd's SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Burning Rock Biotech Ltd.